Coinfections with Hepatitis B virus and Hepatitis C virus among tuberculosis patients in Jos, Nigeria
Sri Ramachandra Journal of Health Sciences · 02.09.2023 · 3 · 14-18
DOI: 10.25259/srjhs_6_2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sri Ramachandra Journal of Health Sciences, online erschienen am 02.09.2023. Verfasst von Yusuf Amuda Agabi und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study investigated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among tuberculosis (TB) patients in Jos, Nigeria. Materials and Methods: Seventy-one (71) TB-positive individuals visiting anti-retroviral clinics (male and female between the ages of 15–55 years) were enrolled in the study. Questionnaires and consent forms were issued to these patients after obtaining ethical clearance for the study. Two milliliters of blood samples were obtained from each TB-positive individual by venipuncture and were analyzed using a hepatitis B and C rapid kit (Solid rapid test kit manufactured by Hangzhou Deangel Biological Engineering Co., Ltd. China). Analysis of data was performed with version 26 of SPSS software.
Results
Out of the seventy-one (71) TB patients recruited in the research, 4 (5.6%) and 2 (2.8%) patients had hepatitis B and C virus, respectively. In this study, HBV seroprevalence, 3 (13.1%) and 1 (11.1%) were recorded among two age groups: 26–30 and 36–40 years, respectively. HCV seroprevalence, 2 (9.1%) was reported within the age group 26–30 years only. The age group and the prevalence of HBV and HCV among the study subjects had no statistically significant relationship ( P > 0.05). Of the 37 females examined, 2 (5.4%) were positive for HBV or HCV, respectively, while of the 34 males, 2 (5.9%) had only HBV. The variables which showed no significant relationship with hepatitis B and C virus were age ( P = 0.423; P = 0.436), sex ( P = 0.660; P = 0.268), newly diagnosed TB patients and those on treatment ( P = 0.416; P = 0.111), blood transfusion ( P = 0.433; P = 0.330), illegitimate sex ( P = 0.668; P = 0.239), tattoo ( P = 0.298; P = 0.298), human immunodeficiency virus status ( P = 0.542; P = 0.654), use of sharp objects ( P = 0.409; P = 0.686), and knowledge of the virus ( P = 0.702; P = 0.614) as P > 0.05. In addition, variables that showed a significant relationship with HCV infection are those that have not been vaccinated with hepatitis B ( P = 0.015) as P < 0.05.
Conclusion
TB patients attending the Faith Alive Foundation Hospital and Plateau Specialist State Hospital, Jos have a low seroprevalence of HBV and HCV and it is recommended that more sensitive and reliable diagnostic options such as enzyme-linked immunosorbent assay and polymerase chain reaction are employed in further studies. TB patients seropositive for HBV or HCV were referred to physicians for appropriate management to prevent complications and the likelihood of damage to the liver as a result of treatment with drugs against TB.
Zitieren
APA
Agabi, Y. A., Onyedikachukwu, A. J., Udeogu, K. E., Chukwu, C., Nkup, J. Y., Okojokwu, O. J., Okop, K. J., & Gomerep, S. S. (2023). Coinfections with Hepatitis B virus and Hepatitis C virus among tuberculosis patients in Jos, Nigeria. Sri Ramachandra Journal of Health Sciences, 3, 14-18. https://doi.org/10.25259/srjhs_6_2023
Vancouver
Agabi YA, Onyedikachukwu AJ, Udeogu KE, Chukwu C, Nkup JY, Okojokwu OJ, et al. Coinfections with Hepatitis B virus and Hepatitis C virus among tuberculosis patients in Jos, Nigeria. Sri Ramachandra Journal of Health Sciences. 2023;3:14-18. doi:10.25259/srjhs_6_2023
BibTeX
@article{Agabi2023,
author = {Agabi, Yusuf Amuda and Onyedikachukwu, Alagbu Jennifer and Udeogu, Kosisochukwu Elijah and Chukwu, Chukwu and Nkup, Jude Yunzoom and Okojokwu, Ocheme Julius and Okop, Kufre Joseph and Gomerep, Simji Samuel},
title = {Coinfections with Hepatitis B virus and Hepatitis C virus among tuberculosis patients in Jos, Nigeria},
journal = {Sri Ramachandra Journal of Health Sciences},
year = {2023},
volume = {3},
pages = {14--18},
doi = {10.25259/srjhs_6_2023}
}
EUVIMED